We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RIO:ASXRio Tinto Limited Analysis

Data as of 2026-03-10 - not real-time

A$153.61

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Rio Tinto (RIO.AX) is trading at AU$153.61, comfortably above its 20‑day (AU$163.60) and 50‑day (AU$156.04) SMAs, indicating a short‑term bullish bias despite a bearish MACD histogram and a neutral RSI of 42. The stock sits near a technical support level of AU$150.20 with resistance around AU$170.71, and volume remains stable, supporting the recent four‑day rally driven by anticipation of earnings and merger speculation with Glencore. Fundamentally, Rio Tinto delivers solid margins (gross 28%, operating 25%), strong cash generation (free cash flow ~AU$3.5bn) and a healthy dividend yield of 3.8% with a payout ratio below 62%, but its market price is far above the DCF‑derived fair value of AU$45.96, suggesting significant overvaluation.
The mining sector’s inherent commodity exposure brings medium‑level sector risk, while low beta (0.46) and ample liquidity mitigate market‑wide volatility, though regulatory and geographic risks remain moderate due to global operations and tightening ESG standards. Investors should weigh the short‑term price momentum against the long‑term valuation gap and merger uncertainty when deciding on exposure.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above short‑term moving averages supports momentum
  • Support level at AU$150.20 provides downside cushion
  • Upcoming earnings and merger rumors fuel volatility

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Strong cash flow and dividend yield underpin fundamentals
  • Market price remains far above DCF fair value
  • Potential Glencore merger creates strategic uncertainty

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Long‑term commodity demand supports earnings outlook
  • Dividend sustainability adds shareholder value
  • Valuation premium and ESG/regulatory pressures limit upside

Key Metrics & Analysis

Financial Health

Revenue Growth14.60%
Profit Margin17.29%
P/E Ratio17.8
ROE16.40%
ROA7.86%
Debt/Equity35.43
P/B Ratio2.8
Op. Cash FlowA$16.8B
Free Cash FlowA$3.5B

Technical Analysis

TrendBullish
RSI42.0
SupportA$150.20
ResistanceA$170.71
MA 20A$163.60
MA 50A$156.04
MA 200A$129.71
MACDBearish
VolumeStable
Fear & Greed Index77.07

Valuation

Fair ValueA$45.96
Target PriceA$155.78
Upside/Downside1.41%
GradeOvervalued
TypeBlend
Dividend Yield3.81%

Risk Assessment

Beta0.46
Volatility36.53%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.